Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021. (2022)

First Author: Martin J
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15585/mmwr.mm7124a2

PubMed Identifier: 35709073

Publication URI: http://europepmc.org/abstract/MED/35709073

Type: Journal Article/Review

Volume: 71

Parent Publication: MMWR. Morbidity and mortality weekly report

Issue: 24

ISSN: 0149-2195